AstraZeneca
AstraZeneca's Overview
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biotechnology company with its global headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It focuses on creating innovative medicines for some of the world's most complex diseases across key therapeutic areas: Oncology; Cardiovascular, Renal & Metabolism; Respiratory & Immunology; and Rare Disease. AstraZeneca is committed to pushing the boundaries of science to deliver life-changing medicines to patients globally.
Where is AstraZeneca's Headquarters?
HQ Function
The headquarters serves as the central hub for global operations, strategic decision-making, corporate functions, and is a key site for AstraZeneca's research and development activities.
Notable Features:
The Discovery Centre (DISC) is a state-of-the-art facility with advanced research laboratories, porous design to encourage collaboration, and high sustainability standards. It features open-plan layouts and cutting-edge scientific equipment.
Work Culture:
The work culture at the Cambridge headquarters emphasizes scientific curiosity, collaboration, patient-centricity, and innovation. It aims to foster an environment where scientists can pursue groundbreaking research and develop breakthrough therapies.
HQ Significance:
Its strategic location within the Cambridge Biomedical Campus facilitates collaboration with leading academic institutions, hospitals, research organizations, and biotech companies, fostering an ecosystem of innovation. It represents AstraZeneca's commitment to R&D leadership.
Values Reflected in HQ: The headquarters' design and function reflect AstraZeneca's core values: 'We follow the science,' 'We put patients first,' 'We play to win,' 'We do the right thing,' and 'We are entrepreneurial.'
Location:
AstraZeneca has a significant global presence, operating in over 100 countries. Its worldwide functions include research and development (with major R&D centers in the UK, US, Sweden, and China), manufacturing and supply chain (with numerous sites globally), commercial operations (sales, marketing, and market access), medical affairs, and various corporate support functions. This extensive network enables AstraZeneca to discover, develop, and deliver medicines to patients around the world.
Street Address:
1 Francis Crick Avenue, Cambridge Biomedical Campus
City:
Cambridge
State/Province:
Cambridgeshire
Country:
United Kingdom
AstraZeneca's Global Presence
Gaithersburg, Maryland/United States
Address: One MedImmune Way, Gaithersburg, MD 20878, USA
Serves as a critical center for AstraZeneca's North American operations and a key contributor to its global R&D pipeline for innovative biologic medicines.
Södertälje/Sweden
Address: Gärtunavägen, SE-151 85 Södertälje, Sweden
Plays a crucial role in AstraZeneca's global supply chain and manufacturing network, and maintains strong historical ties to the 'Astra' heritage of the company.
Shanghai/China
Address: Building 1, 1188 Tianxiong Road, Zizhu National Hi-Tech Industrial Development Park, Minhang District, Shanghai, China
Drives AstraZeneca's growth and innovation in China, one of its key emerging markets, and collaborates with local partners to advance healthcare.
Buying Intent Signals for AstraZeneca
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of AstraZeneca
As of April 2025, AstraZeneca' leadership includes:
Investors of AstraZeneca
AstraZeneca has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
AstraZeneca has experienced significant leadership evolution in the past 12 months (mid-2023 to mid-2024), particularly within its R&D leadership and specialized therapy units, alongside strategic board appointments and planned transitions for key executive roles.
Departures
New Appointments:
Technology (Tech Stack) used by AstraZeneca
Discover the tools AstraZeneca uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AstraZeneca Email Formats and Examples
AstraZeneca primarily utilizes a standard corporate email format, which most commonly consists of the employee's first name followed by a period, then their last name, and the company domain '@astrazeneca.com'. While other formats might exist in specific contexts, this is the predominant structure for external communication.
firstname.lastname@astrazeneca.com
Format
jane.doe@astrazeneca.com
Example
85%
Success rate
News and media
AstraZeneca Press Release • June 2, 2024
AstraZeneca's Enhertu demonstrated unprecedented clinically meaningful improvement in progression-free survival in patients with HR-positive, HER2-low metastatic breast cancer in DESTINY-Breast06 Phase III trial
Positive high-level results from the DESTINY-Breast06 Phase III trial showed Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard-of-care chemotherapy in patients with HR-positive, HER2-low (defined as IHC 1+ or IHC 2+/ISH-) metastatic breast cancer following one or more lines of endocrine therapy....more
AstraZeneca Press Release • May 20, 2024
AstraZeneca to build $1.5bn facility in Singapore for antibody drug conjugate manufacturing
AstraZeneca announced an investment of approximately $1.5bn to build a new state-of-the-art facility in Singapore for the manufacturing of antibody drug conjugates (ADCs). This greenfield investment will be AstraZeneca’s first end-to-end ADC manufacturing site, fully incorporating all steps of the manufacturing process at a commercial scale....more
AstraZeneca Press Release • February 16, 2024
AstraZeneca's Tagrisso with chemotherapy approved in the US for 1st-line EGFR-mutated advanced lung cancer
Tagrisso (osimertinib) in combination with chemotherapy was approved in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). The approval followed a priority review by the FDA and was based on the results from the FLAURA2 Phase III trial....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including AstraZeneca, are just a search away.